For LDNers Group/ Aegis - target this research group?

[Guest guest]

Dear LDNers and Aegis, the below link to a newly discovered treatment

for MS brings me to the point where I think this researcher,

mentioned in the link, and her email is attached to it, should be

targetted for research also into LDN. If an acne treatment was

stumbled on as an MS treatment, and who knows why and how that

happened, why not LDN? These researchers and scientists seem to be a

great contact. I want so much to email her (researcher in article)

but thought i'd hold my horses and let every LDNer read and

especially Aegis for getting info together to approach in the most

favourable manner.

What you reckon ppl?

Friday

http://www.news-medical.net/default.asp?id=2098

[Guest guest]

Thanks Friday, Yes minocycline is a promising drug. I will try to

find out, if they tested minocycline out of the blue, or was there

some previous science backing it. I will contact them and get back

to you all.

A

P.S. Some months ago, a MRI based minocycline study was posted on

the board. Am not sure, if it was from the same group or not.

--- In low dose naltrexone , " Friday " <paraschick@y...>

wrote:

> Dear LDNers and Aegis, the below link to a newly discovered

treatment

> for MS brings me to the point where I think this researcher,

> mentioned in the link, and her email is attached to it, should be

> targetted for research also into LDN. If an acne treatment was

> stumbled on as an MS treatment, and who knows why and how that

> happened, why not LDN? These researchers and scientists seem to

be a

> great contact. I want so much to email her (researcher in

article)

> but thought i'd hold my horses and let every LDNer read and

> especially Aegis for getting info together to approach in the most

> favourable manner.

>

> What you reckon ppl?

>

> Friday

>

> http://www.news-medical.net/default.asp?id=2098

[Guest guest]

It has also been determined to be helpful with ALS in a trial somewhere

so sounds like it probably wasn't out of the blue.

aegis_on_ms wrote:

Thanks Friday, Yes minocycline is a promising drug. I will try to

find out, if they tested minocycline out of the blue, or was there

some previous science backing it. I will contact them and get back

to you all.

A

P.S. Some months ago, a MRI based minocycline study was posted on

the board. Am not sure, if it was from the same group or not.

-- .

,-._|\ Covington / Oz \ \_,--.x/ v

[Guest guest]

Still, its gotta make you wonder, how does a totally un-related

medication make it into research for a condition, I mean, did someone

with ALS have acne too? and , whalla - it killed two birds with one

stone and next thing you know a research scientist jumps onto it? My

mind just boggles - why isnt anyone, other than Dr Bihari, seeing the

prospects of LDN here?

Friday

>

[Guest guest]

I think MS, and other conditions, allow us to see the world through

different eyes (at least some of us - like LDN users). As one " fog "

sets in another lifts. We no longer hold the PR, marketing and often

false misconceptions about modern medicine as gospel.

The use of many drugs for conditions other than those On the Label

(yes it is the Off Label thing again) often are the result of

someone noticing a reaction to a condition other than the one they

were looking at. Or someone just testing out a theory. Could some of

these cases acutally be Lyme? Is Lyme more related than thought to

be in the past (being bacterial)? Is mercury and or other

enviromental or toxic agents, and their affect on the liver and

proper digestion (all the supplements and enzyme talk), more

credible than conventional medicine allows for? Is MS really

several " conditions " with similiar symptoms? Auto-immune or not?

I recently read as much as 40% of prescription drugs are used for

OFF LABEL conditions. That is just shy of half!

The reason minocycline is gettig such a good look is probably, in

part, to Alberta being so high in MS and this study taking place

there, and certainly in part becasue Copaxone sees a potential

windfall if it can establish superior results with this duo. This

may be a clue to trials for LDN. It may be easier to get a Copa/LDN

Clinical study done than just LDN. Perhaps with that under our belt,

an LDN alone study would be difficult to ignore.

Just some thoughts,

alan

> Still, its gotta make you wonder, how does a totally un-related

> medication make it into research for a condition, I mean, did

someone

> with ALS have acne too? and , whalla - it killed two birds with

one

> stone and next thing you know a research scientist jumps onto it?

My

> mind just boggles - why isnt anyone, other than Dr Bihari, seeing

the

> prospects of LDN here?

>

> Friday

[Guest guest]

Actually, that is a VERY good idea! Since Copaxone reportedly works

with LDN whereas the other CRABS don't, perhaps Teva would find it

in their best interest to create this sort of niche for themselves.

--- In low dose naltrexone , " alanms1579 " <alanms@c...>

wrote:

> I think MS, and other conditions, allow us to see the world

through

> different eyes (at least some of us - like LDN users). As

one " fog "

> sets in another lifts. We no longer hold the PR, marketing and

often

> false misconceptions about modern medicine as gospel.

>

> The use of many drugs for conditions other than those On the Label

> (yes it is the Off Label thing again) often are the result of

> someone noticing a reaction to a condition other than the one they

> were looking at. Or someone just testing out a theory. Could some

of

> these cases acutally be Lyme? Is Lyme more related than thought to

> be in the past (being bacterial)? Is mercury and or other

> enviromental or toxic agents, and their affect on the liver and

> proper digestion (all the supplements and enzyme talk), more

> credible than conventional medicine allows for? Is MS really

> several " conditions " with similiar symptoms? Auto-immune or not?

>

> I recently read as much as 40% of prescription drugs are used for

> OFF LABEL conditions. That is just shy of half!

>

> The reason minocycline is gettig such a good look is probably, in

> part, to Alberta being so high in MS and this study taking place

> there, and certainly in part becasue Copaxone sees a potential

> windfall if it can establish superior results with this duo. This

> may be a clue to trials for LDN. It may be easier to get a

Copa/LDN

> Clinical study done than just LDN. Perhaps with that under our

belt,

> an LDN alone study would be difficult to ignore.

>

>

> Just some thoughts,

> alan

>

>

> > Still, its gotta make you wonder, how does a totally un-related

> > medication make it into research for a condition, I mean, did

> someone

> > with ALS have acne too? and , whalla - it killed two birds with

> one

> > stone and next thing you know a research scientist jumps onto

it?

> My

> > mind just boggles - why isnt anyone, other than Dr Bihari,

seeing

> the

> > prospects of LDN here?

> >

> > Friday